Twitxy
Saved
@fredhow's profile picture
View on X

Fred Howard

@fredhow

Breast Medical Oncologist @UCCancerCenter | Former chief resident @YaleIMed | Using big data and AI to answer clinical questions in breast cancer care
Chicago, IL Joined March 2009
201 Following 282 Followers 98 Posts

Latest posts 5

Fred Howard @fredhow
Excited to share our study of RSClin in 280k pts doi.org/10.1002/cncr.3… In the lowest risk pts per RSClin-no chemo benefit even if Oncotype high. For high risk-question of OFS vs chemo remains (I vote OFS) Congrats Augustin! @GenomicHealth @folopade @RitaNandaMD @UChicagoBreast
acsjournals.onlinelibrary.wiley.com Validation of the RSClin risk calculator in the National Cancer Data Base Although developed to predict distant recurrence rates, RSClin predictions correlate well with overall survival for patients receiving endocrine therapy with or without chemotherapy. RSClin may...
Fred Howard @fredhow
HER2-Low Breast Cancer Not a Unique Biological Entity, Researchers Say cancertherapyadvisor.com/home/cancer-to… @CancerTherAdvsr @theproffermd @RitaNandaMD @folopade @UChicagoBreast @UCCancerCenter
www.cancertherapyadvisor.com HER2-Low Breast Cancer Not a Unique Biological Entity, Researchers Say There are “minimal prognostic differences” between HER2-low breast cancer and HER2-negative breast cancer, according to researchers.